The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Healthy
Interventions
DRUG

YH4808 NF 100

The number of times : multiple-dose Rout : oral administration

DRUG

YH4808 OF 200

The number of times : multiple-dose Rout : oral administration

DRUG

YH4808 NF 200

The number of times : multiple-dose Rout : oral administration

DRUG

YH4808 NF 400

The number of times : multiple-dose Rout : oral administration

Trial Locations (1)

Unknown

Yonsei Medical Center Severance Hospital Clinical Trials Center, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT02176668 - The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy Subjects | Biotech Hunter | Biotech Hunter